Holen Sie sich die Stockscreener-App
1.88
14.63%
0.24
Handel nachbörslich:
1.90
0.02
+1.06%
Schlusskurs vom Vortag:
$1.64
Offen:
$1.65
24-Stunden-Volumen:
1.29M
Relative Volume:
3.01
Marktkapitalisierung:
$175.85M
Einnahmen:
-
Nettoeinkommen (Verlust:
$1.60M
KGV:
62.67
EPS:
0.03
Netto-Cashflow:
$-62.91M
1W Leistung:
+21.29%
1M Leistung:
+13.94%
6M Leistung:
+12.57%
1J Leistung:
+18.24%
1-Tages-Spanne:
$1.65
$1.905
1-Wochen-Bereich:
$1.51
$1.905
52-Wochen-Spanne:
$1.13
$2.66
Compugen Ltd Stock (CGEN) Company Profile
Vergleichen Sie CGEN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CGEN
Compugen Ltd
|
1.88 | 153.40M | 0 | 1.60M | -62.91M | 0.03 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Compugen Ltd Stock (CGEN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-01-13 | Eingeleitet | Oppenheimer | Outperform |
| 2022-08-05 | Herabstufung | Jefferies | Buy → Hold |
| 2020-05-26 | Fortgesetzt | JMP Securities | Mkt Outperform |
| 2020-05-13 | Eingeleitet | Stifel | Buy |
| 2020-05-07 | Eingeleitet | SVB Leerink | Outperform |
| 2020-04-22 | Eingeleitet | ROTH Capital | Buy |
| 2020-03-24 | Eingeleitet | SunTrust | Buy |
| 2020-01-16 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-03-29 | Eingeleitet | Oppenheimer | Outperform |
| 2016-02-01 | Fortgesetzt | Oppenheimer | Outperform |
| 2015-10-15 | Eingeleitet | FBR Capital | Outperform |
| 2015-04-23 | Fortgesetzt | Jefferies | Buy |
| 2015-04-21 | Eingeleitet | Oppenheimer | Outperform |
| 2014-02-07 | Eingeleitet | MLV & Co | Buy |
| 2009-12-28 | Bestätigt | Cantor Fitzgerald | Buy |
| 2009-07-29 | Eingeleitet | Cantor Fitzgerald | Buy |
Alle ansehen
Compugen Ltd Aktie (CGEN) Neueste Nachrichten
Why Compugen Ltd. stock could benefit from AI revolutionRate Cut & Intraday High Probability Alerts - ulpravda.ru
Brokers Issue Forecasts for Compugen FY2025 Earnings - Defense World
Compugen (NASDAQ:CGEN) Coverage Initiated at HC Wainwright - Defense World
Compugen rises on royalty deal with AstraZeneca - MSN
Comparing Compugen (NASDAQ:CGEN) & Psyence Biomedical (NASDAQ:PBM) - Defense World
How buybacks impact Compugen Ltd. stock valueRate Hike & Capital Efficiency Focused Strategies - ulpravda.ru
Why Compugen Ltd. stock could rally in 2025Quarterly Portfolio Review & AI Optimized Trading Strategy Guides - ulpravda.ru
Will Compugen Ltd. stock benefit from infrastructure spending2025 Dividend Review & Low Volatility Stock Suggestions - ulpravda.ru
Is Compugen Ltd. stock a bargain at current levelsMoving Average Strategies & Expert-Backed Recommendations That Deliver - ulpravda.ru
H.C. Wainwright initiates coverage on Compugen stock with Buy rating By Investing.com - Investing.com South Africa
Compugen (CGEN): HC Wainwright Initiates Coverage with 'Buy' Rat - GuruFocus
H.C. Wainwright initiates coverage on Compugen stock with Buy rating - Investing.com India
This Applied Digital Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday - Benzinga
HC Wainwright & Co. Initiates Coverage of Compugen (CGEN) with Buy Recommendation - Nasdaq
Operating cash flow per share of Compugen Ltd. – TASE:CGEN - TradingView — Track All Markets
Will Compugen Ltd. stock benefit from sector rotationWeekly Profit Summary & Daily Growth Stock Tips - Улправда
Is Compugen Ltd. stock a defensive play in 2025Portfolio Gains Summary & Real-Time Volume Analysis Alerts - Улправда
Can Compugen Ltd. stock deliver strong Q4 earningsJuly 2025 Analyst Calls & Safe Capital Growth Stock Tips - Улправда
Compugen Secures $90 Million in a Strategic Royalty Monetization Deal with AstraZeneca - The Globe and Mail
Compugen shares jump after $65 million royalty monetization deal with AstraZeneca - MSN
Compugen (CGEN) Rises on Royalty Deal with AstraZeneca - GuruFocus
Compugen restructures AstraZeneca deal to boost cash coffers - גלובס
Compugen stock soars on $65 million AstraZeneca royalty deal By Investing.com - Investing.com Nigeria
Compugen stock soars on $65 million AstraZeneca royalty deal - Investing.com
Compugen Monetizes Portion of Cancer Treatment Future Royalties to AstraZeneca for Up to $90 Million - marketscreener.com
Compugen rises on royalty deal with AstraZeneca (CGEN:NASDAQ) - Seeking Alpha
Compugen monetizes portion of cancer drug royalties to AstraZeneca By Investing.com - Investing.com South Africa
Compugen monetizes portion of cancer drug royalties to AstraZeneca - Investing.com
Compugen monetizes portion of rilvegostomig future royalties to AstraZeneca for up to $90 million - marketscreener.com
Compugen Ltd. and Medimmune Limited Enter into Amendment Number 4 to the License Agreement - marketscreener.com
Compugen Monetizes Portion Of Rilvegostomig Future Royalties To Astrazeneca For Up To $90 Million - TradingView — Track All Markets
[6-K] COMPUGEN LTD Current Report (Foreign Issuer) | CGEN SEC FilingForm 6-K - Stock Titan
Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca for Up to $90 Million - marketscreener.com
Cancer immunotherapy royalty deal brings biotech up to $90M in funding - Stock Titan
Compugen secures $90 million in a strategic royalty monetization deal with AstraZeneca - MSN
Revenue per share of Compugen Ltd. – TASE:CGEN - TradingView — Track All Markets
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Compugen Presents Promising COM701 Analysis at ESMO 2025 - MSN
Compugen’s Former Head Reflects on Computational Discovery, Strategic Collaborations And AI - Citeline News & Insights
Compugen (NASDAQ:CGEN) Share Price Passes Above 200 Day Moving AverageTime to Sell? - MarketBeat
Compugen Ltd (CGEN) Stock Price & 30 Year Financial Data - GuruFocus
Compugen (NASDAQ:CGEN) versus PepGen (NASDAQ:PEPG) Critical Review - Defense World
Can Compugen Ltd. stock beat analyst upgrades2025 Risk Factors & AI Based Buy and Sell Signals - newser.com
What indicators show strength in Compugen Ltd.Layoff News & Fast Momentum Entry Tips - newser.com
Is Compugen Ltd. stock oversold or undervaluedJuly 2025 Trade Ideas & Community Verified Trade Alerts - newser.com
Finanzdaten der Compugen Ltd-Aktie (CGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):